Evidence map›Paper›PMID 35485455›Full record

ArticleLupus2022

New-onset lupus nephritis associated with COVID-19 infection.

Brigitte Kazzi, Derek Fine, Duvuru Geetha, Melody Chung, Manny Monroy-Trujillo, Homa Timlin

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Lupus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Observational
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Brigitte Kazzi1466Johns Hopkins University, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-8198-9089
Derek FineJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Duvuru Geetha1466Johns Hopkins University, Baltimore, MD, USA.
Melody ChungJohns Hopkins University School of Medicine, Baltimore, MD, USA.
Manny Monroy-Trujillo1466Johns Hopkins University, Baltimore, MD, USA.
Homa TimlinHopkins, Baltimore, MD, USA.
Johns Hopkins University · USUniversity of Baltimore · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A dysregulated immune response plays a critical role in systemic lupus erythematosus (SLE) pathogenesis. Environmental factors such as viruses, including coronavirus 2 (COVID-19), have been described to play a role in SLE presentation and exacerbation. These viruses trigger a host's humoral and cellular immunities typically essential in elimination of the viral infection. We present a case of a Hispanic male who developed new-onset lupus nephritis class II after a COVID-19 infection.

Indexed as

COVID-19Lupus Erythematosus, SystemicLupus NephritisHumansMaleCOVID-19lupus nephritissystemic lupus erythematosus

Identifiers

PMID35485455
PMCPMC9066225
OpenAlexW4225135656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.